لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Tierens A; Laboratory Medicine Program, University Health Network, Toronto General Hospital, Toronto, ON, Canada., Arad-Cohen N; Department of Pediatric Hemato-Oncology, Rambam Health Care Campus, Haifa, Israel., Cheuk D; Department of Pediatrics and Adolescent Medicine, Hong Kong Children's Hospital and Hong Kong Pediatric Hematology and Oncology Study Group (HKPHOSG), Hong Kong, China., De Moerloose B; Department of Pediatric Hematology-Oncology, Ghent University Hospital, Gent, Belgium., Fernandez Navarro JM; Department of Pediatric Hemato-Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Hasle H; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Jahnukainen K; New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Juul-Dam KL; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Kaspers G; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Amsterdam, the Netherlands., Kovalova Z; Department of Paediatric Oncology/Haematology, Children's Clinical University Hospital, Riga, Latvia., Lausen B; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Norén-Nyström U; Department of Clinical Sciences, Pediatrics, Umeå University, Umea, Sweden., Palle J; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden., Pasauliene R; Center of Oncology and Hematology, BMT Unit, Vilnius University Children's Hospital, Vilnius, Lithuania., Jan Pronk C; Childhood Cancer Center, Skåne University Hospital, Lund, Sweden., Saks K; Department of Paediatrics, SA Tallinna Lastehaigla, Tallinn, Estonia., Zeller B; Department of Pediatrics, Oslo University Hospital, Oslo, Norway., Abrahamsson J; Institution for Clinical Sciences, Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 20; Vol. 42 (18), pp. 2174-2185. Date of Electronic Publication: 2024 Apr 11.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Comparative Study; Multicenter Study

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Mitoxantrone*/administration & dosage , Daunorubicin*/administration & dosage , Daunorubicin*/therapeutic use , Neoplasm, Residual* , Leukemia, Myeloid, Acute*/drug therapy , Liposomes* , Flow Cytometry* , Nucleophosmin*, Humans ; Child ; Male ; Child, Preschool ; Female ; Infant ; Adolescent ; Risk Assessment ; Hematopoietic Stem Cell Transplantation/methods ; Induction Chemotherapy/methods ; Antibiotics, Antineoplastic/administration & dosage ; Antibiotics, Antineoplastic/therapeutic use

المؤلفون: Benítez Carabante MI; Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d´Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Bueno D; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario La Paz, idiPAZ Research Institute, Madrid, Spain., Alonso García L; Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d´Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., López Torija I; Department of Pediatric Hematology and Oncology, Hospital Santa Creu i Sant Pau, Barcelona, Spain., Marsal J; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, Barcelona, Spain., Fernandez Navarro JM; Department of Pediatric Hematology and Oncology, Hospital Universitari i Politècnic la Fe, Valencia, Spain., Uria Oficialdegui ML; Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d´Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Panesso M; Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d´Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Molina B; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Beléndez Bieler C; Department of Pediatric Hematology and Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Palomo P; Department of Pediatric Hematology and Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain., Pérez Martínez A; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario La Paz, idiPAZ Research Institute, Madrid, Spain., Diaz-de-Heredia C; Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d´Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Electronic address: cristina.diazdeheredia@vallhebron.cat.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jun; Vol. 30 (6), pp. 601.e1-601.e13. Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Thrombotic Microangiopathies*/drug therapy , Thrombotic Microangiopathies*/etiology , Hematopoietic Stem Cell Transplantation*/adverse effects, Humans ; Retrospective Studies ; Male ; Female ; Child ; Risk Factors ; Child, Preschool ; Adolescent ; Treatment Outcome ; Infant ; Spain/epidemiology ; Complement Inactivating Agents/therapeutic use

المؤلفون: Arad-Cohen N; Department of Pediatric Hemato-Oncology, Rambam Health Care Campus, Haifa, Israel., Zeller B; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Abrahamsson J; Department of Paediatrics, Queen Silvia Children's Hospital, Institution for Clinical Sciences, Gothenburg, Sweden., Fernandez Navarro JM; Department of Pediatric Hemato-Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Cheuk D; Department of Pediatrics, Queen Mary Hospital, Hong Kong Pediatric Hematology & Oncology Study Group (HKPHOSG), Hong Kong., Palmu S; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Costa V; Departament of Paediatrics, Instituto Português de Oncologia, FG-Porto, Portugal., De Moerloose B; Department of Paediatrics, Ghent University Hospital, Ghent, Belgium., Hasle H; Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Jahnukainen K; Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Pronk CJ; Childhood Cancer Centre, Skåne University Hospital, Lund, Sweden., Gísli Jónsson Ó; Department of Pediatrics, Landspitali University Hospital, Reykjavík, Iceland., Kovalova Z; Department of Paediatrics, Children's Clinical University Hospital, Riga, Latvia., Lausen B; Department of Paediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Munthe-Kaas M; Pediatric Department, Women and Children's Division, Oslo University Hospital, Oslo, Norway., Noren-Nyström U; Department of Pediatrics, Umeå University Hospital, Umeå, Sweden., Palle J; Department of Woman's and Children's Health, Uppsala University, Uppsala, Sweden., Pasauliene R; Center of Oncology and Hematology, BMT unit, Vilnius University Children's Hospital, Vilnius, Lithuania., Saks K; Department of Paediatrics, SA Tallinna Lastehaigla, Tallinn, Estonia., Kaspers GJ; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands.

المصدر: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2022 Nov; Vol. 22 (11), pp. 1183-1196. Date of Electronic Publication: 2022 Oct 28.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/pathology , Typhlitis*, Adolescent ; Child ; Humans ; Cardiotoxicity